Pomalidomide-PEG4-C2-NH2

CAS No. 2225940-52-1

Pomalidomide-PEG4-C2-NH2 ( Cereblon Ligand-Linker Conjugates 8; E3 Ligase Ligand-Linker Conjugates 22 )

Catalog No. M26946 CAS No. 2225940-52-1

Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 Get Quote
5MG 70 Get Quote
10MG 105 Get Quote
25MG 176 Get Quote
50MG 263 Get Quote
100MG 410 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pomalidomide-PEG4-C2-NH2
  • Note
    Research use only, not for human use.
  • Brief Description
    Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.
  • Description
    Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.
  • Synonyms
    Cereblon Ligand-Linker Conjugates 8; E3 Ligase Ligand-Linker Conjugates 22
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Glucocorticoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2225940-52-1
  • Formula Weight
    492.5
  • Molecular Formula
    C23H32N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCCOCCOCCOCCOCCNc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lorscheider M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release. 2019 Feb 28;296:179-189.
molnova catalog
related products
  • SKLB1002

    SKLB1002 is a potent and ATP-competitive VEGFR2 inhibitor with IC50 of 32 nM.

  • Salirasib

    Salirasib(Ki=2.6 μM), an effective competitive prenylated protein methyltransferase (PPMTase) inhibitor, inhibits Ras methylation with potential antineoplastic activity.

  • 7-Methylcoumarin

    7-Methylcoumarin with strong hepatoprotective activity.